← Back to headlines
Biocon Chief Warns on GLP-1 Drugs, Zerodha CEO Notes Weak Demand
The head of Biocon has issued a warning regarding GLP-1 drugs, while the CEO of Zerodha has highlighted a period of weak market demand.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
